ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/21/2022
Closing price: 68.51
Support price level: $65.08
Resistance price level: $70.78
Relative strength index (14-day RSI) 23.4
Beta 0.26
  • The price of this low-beta stock is expected to increase by 0.26% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.

  • Price crossed below 50-day moving average this week - a bearish signal.

Low High Price as % of Range
$61.40 $73.64 60.3%
200 day 50 day 20 day 10 day
$68.89 $70.52 $71.70 $70.74
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
26.1% 20.2% 22.8% 25.1%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 6.2% in the next week.

  • 14.2% in the next month.

  • 47.2% in the next year.